Cell Signalling and Therapeutics (C7118)

15 credits, Level 6

Autumn teaching

On this module, you’ll explore major signalling pathways in cells, and how disruption in these pathwards can lead to uncontrolled growth and cancer.

From a research scientist perspective, you’ll learn how developing knowledge in the mechanics of these pathways can lead to the design and use of successful cancer treatments. You’ll focus on breast cancer and glioblastoma.

You’ll cover a range of these pathways, including:

• RTKs
• Ras-Raf-MEK-ERK
• PI-3-kinase, AKT and mTOR
• JAK-STAT
• integrins
• hypoxia and angiogenesis.

We regularly review our modules to incorporate student feedback, staff expertise, as well as the latest research and teaching methodology. We’re planning to run these modules in the academic year 2026/27. However, there may be changes to these modules in response to feedback, staff availability, student demand or updates to our curriculum.

We’ll make sure to let you know of any material changes to modules at the earliest opportunity.

Courses

This module is offered on the following courses:

• Biochemistry (with an industrial placement year) BSc
• Biochemistry BSc
• Biochemistry MSci
• Biology BSc
• Biology MSci
• Biomedical Science BSc
• Biomedical Science MSci
• Genetics BSc
• Genetics MSci
• Medical Neuroscience BSc
• Medical Neuroscience MSci
• Neuroscience BSc
• Neuroscience MSci
• Neuroscience with Psychology BSc